We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Serum and Exhaled Breath Condensate MALDI-MS of Lung Cancer. (SPORE)

This study has been terminated.
(This study competed with another VICC study)
Sponsor:
ClinicalTrials.gov Identifier:
NCT00898209
First Posted: May 12, 2009
Last Update Posted: June 24, 2014
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborator:
National Cancer Institute (NCI)
Information provided by (Responsible Party):
Pierre P. Massion, MD, Vanderbilt-Ingram Cancer Center
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: December 2009
  Primary Completion Date: February 2009 (Final data collection date for primary outcome measure)